Diabetic Nephropathy
📧 Sign up to get email alerts when something new happens for Diabetic Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-02-13Clinical Trial Update: A Crossover Study With Hexalacton in Patients With Type 1 Diabetes and Microalbuminuria [Phase 4]
Phase 4 crossover trial evaluating Hexalacton in patients with Type 1 diabetes mellitus and diabetic nephropathy; the current status of the …
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria [Phase 2]
A Phase 2 study of alagebrium in insulin-dependent Type 1 diabetes with microalbuminuria was terminated; the update notes the trial status b…
-
CLINICAL_TRIALS trial_result · 2008-12-17Clinical Trial Update: A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril [Phase 4]
Phase 4 trial evaluating the effect on albuminuria after 24 weeks of treatment with valsartan, benazepril, or their combination in patients …
-
CLINICAL_TRIALS trial_result · 2008-10-31Clinical Trial Update: Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy [Phase 3]
Phase 3 evaluation study of DiaNe for diabetic nephropathy has been completed.
-
CLINICAL_TRIALS trial_result · 2008-10-20Clinical Trial Update: Adiponectin and Insulin Resistance in Diabetic Nephropathy [NA]
A completed clinical trial from Xi'an Jiaotong University examined adiponectin and insulin resistance in diabetic nephropathy. The study sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Spironolactone for Reducing Proteinuria in Diabetic Nephropathy [NA]
A VA-sponsored clinical trial evaluating spironolactone to reduce proteinuria in diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-20Clinical Trial Update: Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With Nephropathy [Phase 3]
A Phase 3 trial evaluating telmisartan alone and in combination with ramipril for diabetic nephropathy in type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-19Clinical Trial Update: The Effect of Folic Acid Administration in the Progression of Microalbuminuria [NA]
This is a completed clinical trial evaluating folic acid for the progression of microalbuminuria in patients with diabetic nephropathy and h…
-
FDA label_change · 2008-08-14FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Amici Pharma, Inc)
FDA approved a supplemental application for enalapril maleate from Amici Pharma, Inc., resulting in labeling changes for the product.
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) [Phase 4]
A Phase 4 trial (TANDEM) comparing Tarka (trandolapril/verapamil) with Lotrel (amlodipine/benazepril) in hypertensive, diabetic patients wit…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) [Phase 4]
This update reports the completion of the Phase 4 BENEDICT trial evaluating prevention of kidney disease in diabetic patients. The study inc…
-
FDA approval · 2008-06-18FDA Approved: RAMIPRIL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for ramipril, authorizing the marketing of a generic ramipril product.
-
CLINICAL_TRIALS trial_result · 2008-05-08Clinical Trial Update: The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria [Phase 4]
A completed Phase 4 study assessing the effect of renin-angiotensin system blockade on PTX3 levels in diabetic patients with proteinuria.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy [Phase 2, Phase 3]
This clinical trial update reports a comparison of captopril alone versus captopril plus pentoxifylline for reducing proteinuria in diabetic…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) [Phase 3]
A Phase 3 trial evaluating chronic intermittent intravenous insulin therapy for diabetic nephropathy and diabetic retinopathy has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-12Clinical Trial Update: Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus [Phase 1]
Phase 1 safety study of FG-3019 (fresolimumab) in incipient diabetic nephropathy due to type 1 or type 2 diabetes has been completed.
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy [Phase 1, Phase 2]
This report covers a Phase 1/Phase 2 clinical trial evaluating aliskiren, irbesartan, and their combination in hypertensive patients with ty…
-
CLINICAL_TRIALS trial_result · 2007-11-21Clinical Trial Update: Adiponectin in Obese Women With T2DN and Effects by RAS Blocker [NA]
This clinical trial update notes completion of a study evaluating adiponectin in obese women with type 2 diabetes and diabetic nephropathy, …
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension [Phase 2]
Phase 2 study evaluating the efficacy and safety of daglutril vs placebo added to losartan in adults with type 2 diabetes, overt nephropathy…
-
FDA approval · 2007-11-13FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), approving an additional change to the approved ANDA…
-
CLINICAL_TRIALS trial_result · 2007-11-12Clinical Trial Update: Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy [Phase 2, Phase 3]
Phase 2/3 trial evaluating the efficacy of N-Acetylcysteine for overt diabetic nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy [Phase 1]
A Phase 1 trial evaluated the long-term effects of soy consumption on cardio-renal indices and C-reactive protein in individuals with type 2…
-
CLINICAL_TRIALS trial_result · 2007-10-05Clinical Trial Update: To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy [Phase 3]
Phase 3 trial of avosentan for diabetic nephropathy was terminated; the update does not provide results.
-
CLINICAL_TRIALS trial_result · 2007-08-02Clinical Trial Update: Angiotensin II Antagonism of TGF-Beta 1 [NA]
Clinical trial on Angiotensin II antagonism of TGF-Beta 1 in diabetic nephropathy and hypertension completed.
-
CLINICAL_TRIALS research · 2007-07-09Clinical Trial Update: Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
A population-based study is evaluating whether rosiglitazone use influences the clinical course of diabetic nephropathy. The status of the s…